Apolipoprotein E ε4 allele frequency in vascular dementia

Dementia and Geriatric Cognitive Disorders

Volumn 22, Issue 1, 2006, Pages 15-19

  Davidson, Yvonne ^a   Gibbons, Linda ^a   Purandare, Nitin ^b   Byrne, Jane ^b   Hardicre, Jayne ^b   Wren, Joanne ^b   Payton, Antony ^b   Pendleton, Neil ^a   Horan, Michael ^a   Burns, Alistair ^b   Mann, David M A ^a,b  

^a HOPE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Alzheimer's disease; APOE 4 allele; Vascular dementia

Indexed keywords

APOLIPOPROTEIN E ESILON 4; APOLIPOPROTEIN E4; UNCLASSIFIED DRUG; APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; ETHNOLOGY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; ALZHEIMER DISEASE; GENETICS; GENOTYPE; MIDDLE AGED; UNITED KINGDOM;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; DEMENTIA, VASCULAR; FEMALE; GENE FREQUENCY; GENOTYPE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED;

EID: 33745207167     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092960     Document Type: Article

References (35)

1. Caplan LR: Binswanger's disease revisited. Neurology 1995;45:626-633.
2. Loeb C: Binswanger's disease is not a single entity. Neurol Sci 2000;21:343-348.
3. Vinters HV, Ellis WG, Zarow C, Zaias BW, Jagust WJ, Mack WJ, Chui HC: Neuropathologic substrates of ischaemic vascular dementia. J Neuropathol Exp Neurol 2000;59:931-945.
4. Brun A, Englund E: White matter disorders in dementia of the Alzheimer type: biochemical and neuropathological correlates. Ann Neurol 1986;19:253-262.
5. Ferrer I, Bella R, Marti SE, Guionnet N: Arteriosclerotic leucoencephalopathy in the elderly and its relation to white matter lesions in Binswanger's disease, multi-infarct encephalopathy and Alzheimer s disease. J Neurol Sci 1990;98:37-50.
6. Tominoto H, Akiguchi I, Akiyama H, Ikeda K, Wakita H, Lin J-X, Budka H: Vascular changes in white matter lesions of Alzheimer's disease. Acta Neuropathol 1999;97:629-634.
7. Tian J, Shi J, Bailey K, Mann DMA: Relationships between arteriosclerosis and cerebral amyloid angiopathy and myelin loss from the cerebral cortical white matter in Alzheimer's disease. Neuropathol Appl Neurobiol 2003;30:46-56.
8. Luchsinger JA, Mayeux R: Cardiovascular risk factors and Alzheimer's disease. Curr Atheroscler Rep 2004;6:261-266.
9. Kalaria RN, Kenny RA, Ballard CG, Perry R, Ince P, Polvikoski T: Towards defining the neuropathological substrates of vascular dementia. J Neurol Sci 2004;226:75-80.
10. Kamboh MI: Molecular genetics of late onset Alzheimers disease. Ann Hum Genet 2004;68:381-404.
11. Hixon JE: Apolipoprotein E polymorphisms affect atherosclerosis in young males. Pathobiological determinants of atherosclerosis in youth (PDAY) Research Group. Arterioscler Thromb 1991;11:1237-1244.
12. Wilson PW, Myers RH, Larson MG, Ordovas JM: Apolipoproein E alleles and risk of coronary disease: a meta-analysis. Arterioscler Thromb Vasc Biol 1996;16:1250-1255.
13. Basun H, Corder EH, Guo Z, Lannfelt L, Corder LS, Manton KG, Winblad B, Viitanen M: Apolipoprotein E polymorphism and stroke in a population sample aged 75 years or more. Stroke 1996;27:1310-1315.
14. Hofman A, Ott A, Breteler M, Slooter AJC, van Harskamp F, van Duijn CN, van Broeckhoven C, Grobbee DE: Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimers disease in the Rotterdam study. Lancet 1997;349:151-154.
15. Slooter AJ, Tang MX, van Duijn CM, Stern Y, Ott A, Bell K, Breteler MM, van Broeckhoven C, Tatemichi TK, Tycko B, Hofman A, Mayeux R: Apolipoprotein E epsilon4 and the risk of dementia with stroke: a population-based study. JAMA 1997;277:818-821.
16. Ji Y, Urakami K, Adachi Y, Maeda M, Isoe K, Kakashima K: Apolipoprotein E polymorphism in patients with Alzheimers disease, vascular dementia and ischaemic vascular disease. Dementia Geriatr Cogn Disord 1998;9:243-245.
17. Kuusisto J, Mykkanen L, Kervinen K, Kesaniemi YA, Laakso M: Apolipoprotein ε4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects. Arterioscler Thromb Vasc Biol 1995;15:1280-1286.
18. McCarron MO, Delong D, Alberts MJ: APOE genotype as a risk factor for ischaemic cerebrovascular disease: a meta-analysis. Neurology 1999;53:1308-1311.
19. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer s disease: Report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
20. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH: Vascular dementia: diagnostic criteria for research studies (report of the NINDS-AIREN International Workshop). Neurology 1993;43:250-260.
21. Purandare N, Daly KJ, Hardicre J, Morris J, Macfarlane G, Burns A, McCollum C: Cerebral emboli: a cause of Alzheimer's and vascular dementia. BMJ, submitted.
22. Rabbitt P, Diggle P, Smith D, Holland F, McInnes L: Identifying and separating the effects of practice and of cognitive ageing during a large longitudinal study of elderly community residents. Neuropsychologia 2001;39:532-543.
23. Wenham PR, Price WH, Blundell G: Apolipoprotein E genotyping by one-stage PCR. Lancet 1991;337:1158-1159.
24. Pendleton N, Payton A, van den Boogerd EH, Holland F, Diggle P, Rabbitt PMA, Horan MA, Worthington J, Ollier WER: Apolipoprotein E genotype does not predict decline in intelligence in healthy older adults. Neurosci Lett 2002;324:74-76.
25. Noguchi S, Murakami S, Yamada N: Apolipoprotein E genotype and Alzheimer's disease. Lancet 1993;342:737.
26. Treves TA, Bornstein NM, Chapman J, Klimovitzki S, Verchovsky R, Asherov A, Veshchev IO, Korczyn AD: APOE-ε4 in patients with Alzheimer's disease and vascular dementia. Alzheimer Dis Assoc Disord 1996;10:189-191.
27. Frisoni GB, Calabresi L, Geroldi C, Bianchetti A, D'Acquarica AL, Govoni S, Sirtori CR, Trabucchi M, Franceschina G: Apolipoprotein E epsilon 4 allele in Alzheimer's disease and vascular dementia. Dementia 1994;5:240-242.
28. Engelborghs S, Dermaut B, Goeman J, Saerens J, Marien P, Pickut BA, Van den Broeck M, Serneels S, Cruts M, Van Broeckhoven C, De Deyn PP: A prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects. J Neurol Neurosurg Psychiatry 2003;74:1148-1151.
29. Hsiung GY, Sadovnik AD, Feldman H: Apolipoprotein E ε4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging. Can Med Assoc J 2004;71:863-867.
30. Kawamata J, Tanaka S, Shimohama S, Uede K, Kimura J: Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia. J Neurol Neurosurg Psychiatry 1994;57:1414-1416.
31. Pirttila T, Lehtimaki T, Rinne J, Marttila K, Frey H, Nikkari T: The frequency of apolipoprotein E4 allele is not increased in patients with probable vascular dementia. Acta Neurol Scand 1996;93:352-354.
32. Traykov L, Rigaud AS, Baudic S, Smagghe A, Boller F, Forette F: Apolipoprotein E ε4 allele frequency in demented and cognitively impaired patients with and without cerebrovascular disease. J Neurol Sci 2002;203-204;177-181.
33. Frank A, Diez-Tejedor E, Bullido MJ, Valdivieso F, Barreiro P: APOE genotype in cerebrovascular disease and vascular dementia. J Neurol Sci 2002;203-204:173-176.
34. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R: Criteria for the diagnosis of ischaemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centres. Neurology 1992;42:473-480.
35. Betard C, Robitaille Y, Gee M, Tiberghien D, Larrivee D, Roy P, Mortin JA, Gauvreau D: Apo E allele frequencies in Alzheimer's disease, Lewy body dementia, Alzheimer's disease with cerebrovascular disease and vascular dementia. Neuroreport 1994;5:1893-1896.